Serveur d'exploration sur les pandémies grippales - Analysis (France)

Index « AbsEn.i » - entrée « immunogenicity »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
immunogenic < immunogenicity < immunoglobulin  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]
Ident.Authors (with country if any)Title
000194 (2018-10-01) Emilie Bayon [France] ; Jessica Morlieras [France] ; Nathalie Dereuddre-Bosquet [France] ; Alexis Gonon [France] ; Leslie Gosse [France] ; Thomas Courant [France] ; Roger Le Grand [France] ; Patrice Marche [France] ; Fabrice Navarro [France]Overcoming immunogenicity issues of HIV p24 antigen by the use of innovative nanostructured lipid carriers as delivery systems: evidences in mice and non-human primates
000448 (2014) Michael Pfleiderer [Allemagne] ; Jean-Hugues Trouvin [France] ; Daniel Brasseur [Belgique] ; Marta Gr Nstrom [Suède] ; Ragini Shivji [Royaume-Uni] ; Manuela Mura [Royaume-Uni] ; Marco Cavaleri [Royaume-Uni]Summary of knowledge gaps related to quality and efficacy of current influenza vaccines
000455 (2014) O. Launay [France] ; P. Y. Boelle [France] ; A. Krivine [France] ; D. Grenet [France] ; V. Boussaud [France] ; N. Remus [France] ; H. Corvol [France] ; F. Chedevergne [France] ; D. Hubert [France] ; I. Sermet-Gaudelus [France]Factors associated with humoral immune response to pandemic A/H1N1(v) 2009 influenza vaccine in cystic fibrosis
000458 (2014) Nathalie Dhedin [France] ; Anne Krivine [France] ; Nicole Le Corre [France] ; Alain Mallet [France] ; Bruno Lioure [France] ; Jacques-Olivier Bay [France] ; Marie-Thérèse Rubio [France] ; Philippe Agape [Réunion] ; Anne Thiebaut [France] ; Jérôme Le Goff [France] ; Brigitte Autran [France] ; Patricia Ribaud [France]Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients
000459 (2014) Corinne Pion [France] ; Virginie Courtois [France] ; Stéphanie Husson [France] ; Marie-Clotilde Bernard [France] ; Marie-Claire Nicolai [France] ; Philippe Talaga [France] ; Emanuelle Trannoy [France] ; Catherine Moste [France] ; Régis Sodoyer [France] ; Isabelle Legastelois [France]Characterization and immunogenicity in mice of recombinant influenza haemagglutinins produced in Leishmania tarentolae
000538 (2013) Carlos A. Diazgranados [États-Unis] ; Andrew J. Dunning [États-Unis] ; Emilia Jordanov [États-Unis] ; Victoria Landolfi [États-Unis] ; Martine Denis [France] ; H. Keipp Talbot [États-Unis]High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: Safety, immunogenicity and relative efficacy during the 2009-2010 season
000594 (2012) B. Rousseau [France] ; P. Loulergue ; O. Mir ; A. Krivine ; S. Kotti ; E. Viel ; T. Simon ; A. De Gramont ; F. Goldwasser ; O. Launay ; C. TournigandImmunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study.
000631 (2012) B. Rousseau [France] ; P. Loulergue [France] ; O. Mir [France] ; A. Krivine [France] ; S. Kotti [France] ; E. Viel [France] ; T. Simon [France] ; A. De Gramont [France] ; F. Goldwasser [France] ; O. Launay [France] ; C. Tournigand [France]Immunogenicity and safety of the influenza A HINIv 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study
000632 (2012) A. Kostianovsky [France] ; P. Charles [France] ; J.-F. Alves [France] ; M. Goulet [France] ; C. Pagnoux [France] ; V. Le Guern [France] ; L. Mouthon [France] ; A. Krivine [France] ; P. Villiger [France, Suisse] ; O. Launay [France] ; L. Guillevin [France]Immunogenicity and safety of seasonal and 2009 pandemic A/H1N1 influenza vaccines for patients with autoimmune diseases: a prospective, monocentre trial on 199 patients
000722 (2011) Odile Launay [France] ; Corinne Desaint [France] ; Christine Durier [France] ; Pierre Loulergue [France] ; Xavier Duval [France] ; Christine Jacomet [France] ; Gilles Pialoux [France] ; Jade Ghosn [France] ; François Raffi [France] ; David Rey [France] ; Faiza Ajana [France] ; Nathalie Colin De Verdiere [France] ; Jacques Reynes [France] ; Valérie Foubert [France] ; François Roman [Belgique] ; Jeanne-Marie Devaster [Belgique] ; Jean-Frangois Delfraissy [France] ; Jean-Pierre Aboulker [France]Safety and Immunogenicity of a Monovalent 2009 Influenza A/H1N1v Vaccine Adjuvanted With AS03A or Unadjuvanted in HIV-Infected Adults: A Randomized, Controlled Trial
000730 (2011) Vassilis Tsatsaris [France] ; Catherine Capitant ; Thomas Schmitz ; Corine Chazallon ; Sophie Bulifon ; Didier Riethmuller ; Olivier Picone ; Patrice Poulain ; Fanny Lewin ; Fabrice Laine ; Evelyne Jacqz-Aigrain ; Jean-Pierre Aboulker ; Odile LaunayMaternal Immune Response and Neonatal Seroprotection From a Single Dose of a Monovalent Nonadjuvanted 2009 Influenza A(H1N1) Vaccine: A Single-Group Trial
000734 (2011) A. Mathian [France] ; H. Devilliers [France] ; A. Krivine [France] ; N. Costedoat-Chalumeau [France] ; J. Haroche [France] ; D. Boutin-Le Thi Huong [France] ; B. Wechsler [France] ; B. Hervier [France] ; M. Miyara [France] ; N. Morel [France] ; N. Le Corre [France] ; L. Arnaud [France] ; J. C. Piette [France] ; L. Musset [France] ; B. Autran [France] ; F. Rozenberg [France] ; Z. Amoura [France]Factors Influencing the Efficacy of Two Injections of a Pandemic 2009 Influenza A (H1N1) Nonadjuvanted Vaccine in Systemic Lupus Erythematosus
000781 (2010) Marc P. Girard [France] ; John S. Tam ; Olga M. Assossou ; Marie Paule KienyThe 2009 A (H1N1) influenza virus pandemic: A review.
000826 (2010) Marc P. Girard [France] ; John S. Tam [Suisse] ; Olga M. Assossou [France] ; Marie Paule Kieny [Suisse]The 2009 A (H1N1 ) influenza virus pandemic: A review
000836 (2010) Ana Canestri [France] ; Anne Krivine [France] ; Lambert Assoumou [France] ; Monique Le Corre [France] ; Flore Rozenberg [France] ; Anne-Geneviève Marcelin [France] ; Luminita Schneider [France] ; Assia Samri [France] ; Guislaine Carcelain [France] ; Brigitte Autran [France] ; Christine Katlama [France] ; Amélie Guihot [France]Maraviroc does not affect humoral response to the pandemic influenza A-H1N1v 2009 adjuvanted vaccine in HIV-1-infected patients
000839 (2010) Eric Plennevaux [France] ; Eric Sheldon [États-Unis] ; Mark Blotter [États-Unis] ; Mary-Kate Reeves-Hoche [États-Unis] ; Martine Denis [France]Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials
000843 (2010) Catherine Caillet [France] ; Fabienne Piras [France] ; Marie-Clotilde Bernard [France] ; Aymeric De Montfort [France] ; Florence Boudet [France] ; Frederick R. Vogel [France] ; Agnès Hoffenbach [France] ; Catherine Moste [France] ; Inca Kusters [France]AF03-adjuvanted and non-adjuvanted pandemic influenza A (H1N1) 2009 vaccines induce strong antibody responses in seasonal influenza vaccine-primed and unprimed mice
000886 (2009) Pierre Loulergue [France] ; Odile Launay [France]Vaccins pandémiques et prépandémiques dirigés contre le virus grippal H5N1
000914 (2009) Judit Szecsi [France] ; Gülsah Gabriel [Allemagne] ; Gabriella Edfeldt [France] ; Maud Michelet [France] ; Hans Dieter Klenk [Allemagne] ; François-Loïc Cosset [France]DNA Vaccination with a Single-Plasmid Construct Coding for Viruslike Particles Protects Mice against Infection with a Highly Pathogenic Avian Influenza A Virus
000937 (2008) Tawee Chotpitayasunondh [Thaïlande] ; Usa Thisyakorn [Thaïlande] ; Chitsanu Pancharoen [Thaïlande] ; Stephanie Pepin [France] ; Nolwenn Nougarede [France]Safety, Humoral and Cell Mediated Immune Responses to Two Formulations of an Inactivated, Split-Virion Influenza A/H5N1 Vaccine in Children
000A23 (2006) Jean-Louis Bresson [France] ; Christian Perronne ; Odile Launay ; Catherine Gerdil ; Melanie Saville ; John Wood ; Katja Höschler ; Maria C. ZambonSafety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/AbsEn.i -k "immunogenicity" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/AbsEn.i  \
                -Sk "immunogenicity" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    immunogenicity
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021